MARKET

SIGA

SIGA

Siga Technologie
NASDAQ
3.000
+0.120
+4.17%
After Hours: 3.000 0 0.00% 19:34 08/14 EDT
OPEN
2.890
PREV CLOSE
2.880
HIGH
3.010
LOW
2.855
VOLUME
588.16K
TURNOVER
--
52 WEEK HIGH
8.51
52 WEEK LOW
2.830
MARKET CAP
215.55M
P/E (TTM)
-75.9494
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SIGA last week (0803-0807)?
Weekly Report · 5d ago
U.S. CDC Says As Of August 6, 2,465 Confirmed Measles Cases Were Reported In U.S. In 2026; There Have Been 38 New Measles Outbreaks Reported In 2026, And 94% Of Confirmed Cases Are Outbreak-Associated
Benzinga · 08/07 15:06
SIGA Technologies GAAP EPS of $0.17, revenue of $41M
Seeking Alpha · 08/06 20:03
SIGA Technologies Q2 EPS $0.17 Down From $0.49 YoY, Sales $41.002M Down From $81.120M YoY
Benzinga · 08/06 20:02
Press Release: SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026
Dow Jones · 08/06 20:01
Press Release: SIGA Reports Financial Results for -2-
Dow Jones · 08/06 20:01
Weekly Report: what happened at SIGA last week (0727-0731)?
Weekly Report · 08/03 09:15
Siga Technologies: Q2 Earnings Due, New TPOXX Orders A Must
Seeking Alpha · 07/28 17:28
More
About SIGA
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.

Webull offers SIGA Technologies Inc stock information, including NASDAQ: SIGA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIGA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SIGA stock methods without spending real money on the virtual paper trading platform.